Intellia Therapeutics, Inc. (20) | Intellectual Property (4)

Browse by Subcategory

License Agreements (4)

Recent Contracts

Amendment #3 to License and Collaborative Research Agreement, dated as of June 14, 2021, by and between Novartis and Intellia (Filed With SEC on June 17, 2021)
License and Collaborative Research Agreement dated as of December 18, 2014 by and between Registrant and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on May 6, 2021)
License Agreement dated as of July 16, 2014 by and between Registrant (as successor in interest of Intellia Therapeutics, LLC) and Caribou Biosciences, Inc (Filed With SEC on May 6, 2021)
Agreement and Amendment to License and Collaborative Research Agreement, dated as of December 3, 2018, by and between Novartis and the Company (Filed With SEC on February 27, 2019)